These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9205018

  • 1. Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).
    Behrens S, Ney G, Fisher SG, Fletcher RD, Franz MR, Singh SN.
    Am J Cardiol; 1997 Jul 01; 80(1):45-8. PubMed ID: 9205018
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amiodarone in congestive heart failure.
    Singh S.
    Int J Clin Pract; 1998 Sep 01; 52(6):432-5. PubMed ID: 9894384
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS, Zehender M.
    Ther Umsch; 2000 May 01; 57(5):324-32. PubMed ID: 10859993
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
    Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH.
    Circulation; 2009 Dec 01; 120(22):2170-6. PubMed ID: 19917887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H, Auricchio A, Reek S, Geller C.
    Am J Cardiol; 1999 Mar 11; 83(5B):91D-97D. PubMed ID: 10089848
    [Abstract] [Full Text] [Related]

  • 11. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.
    N Engl J Med; 2005 Jan 20; 352(3):225-37. PubMed ID: 15659722
    [Abstract] [Full Text] [Related]

  • 12. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.
    Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN.
    Circulation; 1998 Dec 08; 98(23):2574-9. PubMed ID: 9843465
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
    Farré J, Romero J, Rubio JM, Ayala R, Castro-Dorticós J.
    Am J Cardiol; 1999 Mar 11; 83(5B):55D-63D. PubMed ID: 10089841
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT, Reinhall PG, Poole JE, Anderson J, Johnson G, Fletcher RD, Moore HJ, Mark DB, Lee KL, Bardy GH.
    Heart Rhythm; 2015 Oct 11; 12(10):2058-66. PubMed ID: 26096609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ.
    Heart; 1998 Apr 11; 79(4):331-6. PubMed ID: 9616338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.